Table 2.
All (n = 40)
|
ERM (n = 21)
|
MH (n = 14)
|
VO (n = 5)
|
|||||
---|---|---|---|---|---|---|---|---|
SE | FE | SE | FE | SE | FE | SE | FE | |
Central (μm) | 390 ± 105 | 258 ± 29* | 404 ± 99 | 265 ± 31* | 414 ± 105 | 243 ± 25* | 263 ± 18 | 263 ± 11 |
Superior (μm) | 375 ± 69 | 317 ± 24* | 389 ± 60 | 324 ± 25* | 376 ± 84 | 306 ± 24* | 314 ± 16 | 312 ± 6 |
Nasal (μm) | 379 ± 69 | 313 ± 23* | 383 ± 69 | 318 ± 17* | 396 ± 71 | 304 ± 33* | 317 ± 19 | 317 ± 10 |
Inferior (μm) | 372 ± 75 | 311 ± 24* | 383 ± 76 | 319 ± 22* | 379 ± 78 | 300 ± 26* | 309 ± 19 | 310 ± 9 |
Temporal (μm) | 370 ± 78 | 312 ± 28* | 387 ± 72 | 320 ± 31* | 365 ± 93 | 301 ± 22* | 308 ± 16 | 309 ± 14 |
Cube volume (mm3) | 11 ± 1 | 10 ± 1* | 11 ± 1 | 10 ± 1* | 11 ± 2 | 9.9 ± 1 | 9.9 ± 1 | 9.9 ± 0.4 |
Note:
P < 0.05 between study and fellow eyes.
Abbreviations: SD-OCT, spectral-domain optical coherence tomgraphy; ERM, epiretinal membrane; MH, macular hole; VO, vitreous opacities; SE, study eye; FE, fellow eye.